Landscape of tumor-infiltrating T cell repertoire of human cancers
Hodi, F. Stephen
Choueiri, Toni K.
Liu, X. ShirleyNote: Order does not necessarily reflect citation order of authors.
MetadataShow full item record
CitationLi, B., T. Li, J. Pignon, B. Wang, J. Wang, S. Shukla, R. Dou, et al. 2016. “Landscape of tumor-infiltrating T cell repertoire of human cancers.” Nature genetics 48 (7): 725-732. doi:10.1038/ng.3581. http://dx.doi.org/10.1038/ng.3581.
AbstractWe developed a computational method to infer the complementarity determining region 3 (CDR3) sequences of tumor infiltrating T-cells in 9,142 RNA-seq samples across 29 cancer types. We identified over 600 thousand CDR3 sequences, including 15% with full-length. CDR3 sequence length distribution and amino acid conservation, as well as variable gene usage of infiltrating T-cells in many tumors, except brain and kidney cancers, resembled those in the peripheral blood of healthy donors. We observed a strong association between T-cell diversity and tumor mutation load, and predicted SPAG5 and TSSK6 as putative immunogenic cancer/testis antigens in multiple cancers. Finally, we identified 3 potential immunogenic somatic mutations based on their co-occurrence with CDR3 sequences. One of them, PRAMEF4 F300V, was predicted to bind strongly to both MHC-I and MHC-II, with matched HLA types in its carriers. Our analyses have the potential to simultaneously identify immunogenic neoantigens and the tumor-reactive T-cell clonotypes.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:31731849